Showing results (11-20 of 305) with videos related to
Sort By:
Pageof 31
Human Vaccines & Immunotherapeutics|April 8, 2016
Heparanase and cancer progression: New directions, new promisesGil Arvatz, Marina Weissmann, Neta Ilan, et al.Biochemical Pharmacology|February 26, 2014
The potential of heparanase as a therapeutic target in cancerClaudio Pisano, Israel Vlodavsky, Neta Ilan, et al.FEBS Letters|April 26, 2005
Heparanase processing by lysosomal/endosomal protein preparationEsti Cohen, Ruth Atzmon, Israel Vlodavsky, et al.Current Pharmaceutical Design|July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateIsrael Vlodavsky, Neta Ilan, Annamaria Naggi, et al.Plos One|January 28, 2014
Heparanase interacts with resistin and augments its activityDaniela Novick, Sara Barak, Neta Ilan, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.The Journal of Biological Chemistry|June 26, 2010
Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activityFlonia Levy-Adam, Sari Feld, Victoria Cohen-Kaplan, et al.Trends in Biochemical Sciences|September 8, 2009
Heparanase: busy at the cell surfaceLiat Fux, Neta Ilan, Ralph D Sanderson, et al.Plos One|March 3, 2011
Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levelsItay Shafat, Neta Ilan, Samih Zoabi, et al.Biochemical and Biophysical Research Communications|August 11, 2007
Heparanase induces Akt phosphorylation via a lipid raft receptorOlga Ben-Zaken, Svetlana Gingis-Velitski, Israel Vlodavsky, et al.Pageof 31